DGAP-Adhoc

MOLOGEN AG successfully closes capital increase from authorized capital; gross proceeds of EUR 28.29 million

MOLOGEN AG / Key word(s): Capital Increase

22.04.2015 19:13

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

MOLOGEN AG successfully closes capital increase from authorized capital;
gross proceeds of EUR 28.29 million

Berlin, April 22, 2015 - MOLOGEN AG (ISIN DE0006637200/WKN 663720)
successfully placed new shares from the cash capital increase resolved on
24 March 2015 with indirect subscription rights of the existing
shareholders and subsequent international private placement with qualified
investors in the full amount of 5,657,875 shares (corresponds to 33.33 % of
the currently existing share capital). The purchase price in the context of
the private placement was fixed at EUR 5.00 per new share and thus
corresponds to the subscription price for existing shareholders. The share
capital will therefore be increased, through the issuance of 5,657,875 new
bearer shares with no par value, from currently EUR 16,973,626.00 to then
EUR 22,631,501.00. The gross proceeds from the share issuance amount to
approximately EUR 28.29 million. The management board will shortly apply
for the registration of the implementation of the capital increases with
the commercial register.


---------------------------------------------------------------------------

Information and Explaination of the Issuer to this News:

DISCLAIMER
This announcement does not constitute an offer to buy shares or other
securities of MOLOGEN AG and does not replace the prospectus. Investment
decisions with respect to the shares or other securities of MOLOGEN AG
shall only take place on the basis of the prospectus which will be
available after the approval by the German Financial Supervisory Authority
(BaFin) free of charge at MOLOGEN AG.

This announcement does not contain or constitute an offer of, or the
solicitation of an offer to buy or subscribe for, securities to any person
in the United States of America (the 'United States'), Australia, Canada or
Japan or in any jurisdiction to whom or in which such offer or solicitation
is unlawful. The securities referred to in this announcement will not be
and have not been registered under the U.S. Securities Act of 1933, as
amended (the 'U.S. Securities Act') and may not be offered or sold in the
United States absent registration or an applicable exemption from
registration requirements under the U.S. Securities Act. Subject to certain
exceptions,
the securities referred to in this announcement may not be offered or sold
in Australia, Canada or Japan, or to, or for the account or benefit of, any
national, resident or citizen of Australia, Canada or Japan. The offer and
sale of the securities referred to in this announcement has not been and
will not be registered under the U.S. Securities Act or under the
applicable securities laws of Australia, Canada or Japan. There will be no
public offer of the securities in the United States.

Contact

Claudia Nickolaus
Head of Investor Relations & Corporate Communications
Tel: +49 - 30 - 84 17 88 - 38
Fax: +49 - 30 - 84 17 88 - 50
[e-mail]

22.04.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: MOLOGEN AG
Fabeckstraße 30
14195 Berlin
Germany
Phone: 030 / 841788-0
Fax: 030 / 841788-50
E-mail: [e-mail]
Internet: www.mologen.com
ISIN: DE0006637200
WKN: 663720
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------